Citations (88)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Yashpal S Chhonker, Liping Ma, Constant Edi & Daryl J Murry. (2018) A Sensitive and Selective LC–MS/MS Method for Quantitation of Ivermectin in Human, Mouse and Monkey Plasma: Clinical Validation. Bioanalysis 10:22, pages 1841-1852.
Read now
Read now
Erwin van den Enden. (2009) Pharmacotherapy of helminth infection. Expert Opinion on Pharmacotherapy 10:3, pages 435-451.
Read now
Read now
K. Awadzi, G. Edwards, B. O. L. Duke, N. O. Opoku, S. K. Attah, E. T. Addy, A. E. Ardrey & B. T. Quartey. (2003) The co-administration of ivermectin and albendazole - safety, pharmacokinetics and efficacy against Onchocerca volvulus
. Annals of Tropical Medicine & Parasitology 97:2, pages 165-178.
Read now
Read now
Slobodan Rendic. (2002) Summary of information on human CYP enzymes: human P450 metabolism data. Drug Metabolism Reviews 34:1-2, pages 83-448.
Read now
Read now
Articles from other publishers (84)
L. L. M. Marques, S. C. Beneti, C. Pinzon & F. A. R. Cardoso. (2024) Ivermectin as a possible treatment for COVID-19: a review of the 2022 protocols. Brazilian Journal of Biology 84.
Crossref
Crossref
Mohsen Amin & Navid Mirmohammadsadegh. 2024. Encyclopedia of Toxicology. Encyclopedia of Toxicology
857
866
.
Michał Sulik, Michał Antoszczak, Adam Huczyński & Dietmar Steverding. (2023) Antiparasitic activity of ivermectin: Four decades of research into a “wonder drug”. European Journal of Medicinal Chemistry 261, pages 115838.
Crossref
Crossref
Adam M. Fimbo, Eulambius M. Mlugu, Eliford Ngaimisi Kitabi, Gerald S. Kulwa, Mohammed A. Iwodyah, Rajabu Hussein Mnkugwe, Peter P. Kunambi, Alpha Malishee, Appolinary A. R. Kamuhabwa, Omary M. Minzi & Eleni Aklillu. (2023) Population pharmacokinetics of ivermectin after mass drug administration in lymphatic filariasis endemic communities of Tanzania. CPT: Pharmacometrics & Systems Pharmacology 12:12, pages 1884-1896.
Crossref
Crossref
Aeyaz Ahmad Bhat, Atif Khurshid Wani, Tahir ul Gani Mir & Nahid Akther. 2023. Chemistry and Biological Activities of Ivermectin. Chemistry and Biological Activities of Ivermectin
1
21
.
Mustafa M. Abo-Elela & Nermeen A. ElKasabgy. (2023) COVID-19 a global crisis: Features, complications and suggested treatments. International Journal of Clinical Medical Research 1:2, pages 37-48.
Crossref
Crossref
Achaporn Yipsirimetee, Phornpimon Tipthara, Borimas Hanboonkunupakarn, Rupam Tripura, Dysoley Lek, Krittikorn Kümpornsin, Marcus C. S. Lee, Jetsumon Sattabongkot, Arjen M. Dondorp, Nicholas J. White, Kevin C. Kobylinski, Joel Tarning & Kesinee Chotivanich. (2023) Activity of Ivermectin and Its Metabolites against Asexual Blood Stage Plasmodium falciparum and Its Interactions with Antimalarial Drugs. Antimicrobial Agents and Chemotherapy 67:7.
Crossref
Crossref
Charlotte Kern, Pie Müller, Carlos Chaccour, Matthias E. Liechti, Felix Hammann & Urs Duthaler. (2023) Pharmacokinetics of ivermectin metabolites and their activity against Anopheles stephensi mosquitoes. Malaria Journal 22:1.
Crossref
Crossref
Thiago Caetano Andrade Belo, Natália Cristina de Melo Santos, Bianca Silva Souto, Caio Pupin Rosa, Ana de Souza Santos, Karen Cristina Oliveira, Patrícia Paiva Corsetti & Leonardo Augusto de Almeida. (2023) Ivermectin-induced bacterial gut dysbiosis does not increase susceptibility to Pseudomonas aeruginosa lung infection but exacerbates liver damage. Microbes and Infection 25:4, pages 105080.
Crossref
Crossref
Karen Rowland Yeo & David Wesche. (2023) PBPK modeling of ivermectin—Considerations for the purpose of developing alternative routes to optimize its safety profile. CPT: Pharmacometrics & Systems Pharmacology 12:5, pages 598-609.
Crossref
Crossref
Kotaro Takano, Lachlan de Hayr, Scott Carver, Robert J. Harvey & Kate E. Mounsey. (2023) Pharmacokinetic and pharmacodynamic considerations for treating sarcoptic mange with cross-relevance to Australian wildlife. International Journal for Parasitology: Drugs and Drug Resistance 21, pages 97-113.
Crossref
Crossref
Mo’tasem M. Alsmadi. (2023) The investigation of the complex population-drug-drug interaction between ritonavir-boosted lopinavir and chloroquine or ivermectin using physiologically-based pharmacokinetic modeling. Drug Metabolism and Personalized Therapy 38:1, pages 87-105.
Crossref
Crossref
Vanessa Baier, Alicia Paini, Stephan Schaller, Colin G. Scanes, Audrey J. Bone, Markus Ebeling, Thomas G. Preuss, Johannes Witt & David Heckmann. (2022) A generic avian physiologically-based kinetic (PBK) model and its application in three bird species. Environment International 169, pages 107547.
Crossref
Crossref
Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Athanasios Alexiou & Gaber El-Saber Batiha. (2022) Central Effects of Ivermectin in Alleviation of Covid-19-induced Dysauto-nomia. Current Drug Targets 23:13, pages 1277-1287.
Crossref
Crossref
Hoda Awad, Basmala Hassan, Sara Dweek, Yasmeen Aboelata, Mutasem Rawas-Qalaji & Iman Saad Ahmed. (2022) Repurposing Potential of the Antiparasitic Agent Ivermectin for the Treatment and/or Prophylaxis of COVID-19. Pharmaceuticals 15:9, pages 1068.
Crossref
Crossref
Natalie Jakobs, Esra Yilmaz & Jürgen Krücken. (2022) Transgenic Expression of Haemonchus contortus Cytochrome P450 Hco-cyp-13A11 Decreases Susceptibility to Particular but Not All Macrocyclic Lactones in the Model Organism Caenorhabditis elegans. International Journal of Molecular Sciences 23:16, pages 9155.
Crossref
Crossref
Hao Dai, Daoxia Li, Li Xiao, Lin Yang, Songfan Li, Hong Yang, Yanshu Jiang & Yi Ye. (2022) Determination of abamectin in heart blood and urine following lethal intoxication: a case report. Forensic Toxicology 40:2, pages 400-402.
Crossref
Crossref
Mohitosh Biswas, Nares Sawajan, Thanyada Rungrotmongkol, Kamonpan Sanachai, Maliheh Ershadian & Chonlaphat Sukasem. (2022) Pharmacogenetics and Precision Medicine Approaches for the Improvement of COVID-19 Therapies. Frontiers in Pharmacology 13.
Crossref
Crossref
Patricia Nicolas, Caroline Kiuru, Martin G. Wagah, Martha Muturi, Urs Duthaler, Felix Hammann, Marta Maia & Carlos Chaccour. (2021) Potential metabolic resistance mechanisms to ivermectin in Anopheles gambiae: a synergist bioassay study. Parasites & Vectors 14:1.
Crossref
Crossref
Shreshta Jain, Heidrun Potschka, P. Prarthana Chandra, Manjari Tripathi & Divya Vohora. (2021) Management of COVID-19 in patients with seizures: Mechanisms of action of potential COVID-19 drug treatments and consideration for potential drug-drug interactions with anti-seizure medications. Epilepsy Research 174, pages 106675.
Crossref
Crossref
Lovepreet Singh & Kamaljit Singh. (2021) Ivermectin: A Promising Therapeutic for Fighting Malaria. Current Status and Perspective. Journal of Medicinal Chemistry 64:14, pages 9711-9731.
Crossref
Crossref
Slobodan P. Rendic. (2021) Metabolism and interactions of Ivermectin with human cytochrome P450 enzymes and drug transporters, possible adverse and toxic effects. Archives of Toxicology 95:5, pages 1535-1546.
Crossref
Crossref
Urs Duthaler, Michael Weber, Lorenz Hofer, Carlos Chaccour, Marta Maia, Pie Müller, Stephan Krähenbühl & Felix Hammann. (2021) The pharmacokinetics and drug-drug interactions of ivermectin in Aedes aegypti mosquitoes. PLOS Pathogens 17:3, pages e1009382.
Crossref
Crossref
Ingrid Fricke-Galindo & Ramcés Falfán-Valencia. (2021) Pharmacogenetics Approach for the Improvement of COVID-19 Treatment. Viruses 13:3, pages 413.
Crossref
Crossref
Bikash Dangi, Nadezhda Y. Davydova, Marc A. Maldonado, Armina Abbasi, Nikita E. Vavilov, Victor G. Zgoda & Dmitri R. Davydov. (2021) Effects of alcohol-induced increase in CYP2E1 content in human liver microsomes on the activity and cooperativity of CYP3A4. Archives of Biochemistry and Biophysics 698, pages 108677.
Crossref
Crossref
Phornpimon Tipthara, Kevin C. Kobylinski, Markus Godejohann, Borimas Hanboonkunupakarn, Alison Roth, John H. Adams, Nicholas J. White, Podjanee Jittamala, Nicholas P. J. Day & Joel Tarning. (2021) Identification of the metabolites of ivermectin in humans. Pharmacology Research & Perspectives 9:1.
Crossref
Crossref
Janneke M. Brussee, Anna Neodo, Jessica D. Schulz, Jean T. Coulibaly, Marc Pfister & Jennifer Keiser. (2021) Pharmacometric Analysis of Tribendimidine Monotherapy and Combination Therapies To Achieve High Cure Rates in Patients with Hookworm Infections. Antimicrobial Agents and Chemotherapy 65:2.
Crossref
Crossref
Peter A. Kropp, Gabrielle V. Rushing, Asa A. Brockman, Erin N. Z. Yu, Rebecca A. Ihrie & Maureen Gannon. (2020) Unexpected effects of ivermectin and selamectin on inducible CreER activity in mice. Laboratory Animal Research 36:1.
Crossref
Crossref
Takahiro Goto, Yasushi Yamazoe & Masahiro Tohkin. (2020) Applications of a grid-based CYP3A4 Template system to understand the interacting mechanisms of large-size ligands; part 4 of CYP3A4 Template study. Drug Metabolism and Pharmacokinetics 35:6, pages 485-496.
Crossref
Crossref
Showkat Ahmad Dar, Arunava Chatterjee, Mohd Ashraf Rather, Diganta Chetia, Prem P. Srivastava & Subodh Gupta. (2020) Identification, functional characterization and expression profiling of cytochrome p450 1A (CYP1A) gene in Labeo rohita against emamectin benzoate. International Journal of Biological Macromolecules 158, pages 1268-1278.
Crossref
Crossref
Anya Jafari, Sahar Dadkhahfar & Sahra Perseh. (2020) Considerations for interactions of drugs used for the treatment of COVID-19 with anti-cancer treatments. Critical Reviews in Oncology/Hematology 151, pages 102982.
Crossref
Crossref
Kevin C. Kobylinski, Podjanee Jittamala, Borimas Hanboonkunupakarn, Sasithon Pukrittayakamee, Kanchana Pantuwatana, Siriporn Phasomkusolsil, Silas A. Davidson, Markus Winterberg, Richard M. Hoglund, Mavuto Mukaka, Rob W. van der Pluijm, Arjen Dondorp, Nicholas P.J. Day, Nicholas J. White & Joel Tarning. (2019) Safety, Pharmacokinetics, and Mosquito‐Lethal Effects of Ivermectin in Combination With Dihydroartemisinin‐Piperaquine and Primaquine in Healthy Adult Thai Subjects. Clinical Pharmacology & Therapeutics 107:5, pages 1221-1230.
Crossref
Crossref
. (2020) A Roadmap for the Development of Ivermectin as a Complementary Malaria Vector Control Tool. The American Journal of Tropical Medicine and Hygiene 102:2s, pages 3-24.
Crossref
Crossref
Eliška Syslová, Přemysl Landa, Martina Navrátilová, Lucie Raisová Stuchlíková, Petra Matoušková, Lenka Skálová, Barbora Szotáková, Tomáš Vaněk & Radka Podlipná. (2019) Ivermectin biotransformation and impact on transcriptome in Arabidopsis thaliana. Chemosphere 234, pages 528-535.
Crossref
Crossref
Roger K. Prichard & Timothy G. Geary. (2019) Perspectives on the utility of moxidectin for the control of parasitic nematodes in the face of developing anthelmintic resistance. International Journal for Parasitology: Drugs and Drug Resistance 10, pages 69-83.
Crossref
Crossref
Dalia S. Ashour. (2019) Ivermectin: From theory to clinical application. International Journal of Antimicrobial Agents 54:2, pages 134-142.
Crossref
Crossref
Anna Neodo, Jessica D. Schulz, Jörg Huwyler & Jennifer Keiser. (2019)
In Vitro
and
In Vivo
Drug-Drug Interaction Study of the Effects of Ivermectin and Oxantel Pamoate on Tribendimidine
. Antimicrobial Agents and Chemotherapy 63:1.
Crossref
Crossref
J.H. Kim, J.A. Moreau, Y. Ali, P. Razo, K. B. Hong, K.S. Yoon & J.M. Clark. (2018) RNA interference validation of detoxification genes involved in ivermectin tolerance in Drosophila melanogaster. Insect Molecular Biology 27:5, pages 651-660.
Crossref
Crossref
Cengiz Gokbulut & Quintin A. McKellar. (2018) Anthelmintic drugs used in equine species. Veterinary Parasitology 261, pages 27-52.
Crossref
Crossref
Raj Badhan, Zaril Zakaria & Olusola Olafuyi. (2018) The Repurposing of Ivermectin for Malaria: A Prospective Pharmacokinetics-Based Virtual Clinical Trials Assessment of Dosing Regimen Options. Journal of Pharmaceutical Sciences 107:8, pages 2236-2250.
Crossref
Crossref
Jessica D. Schulz, Anna Neodo, Jean T. Coulibaly & Jennifer Keiser. (2018)
Development and validation of a LC-MS/MS method for ivermectin quantification in dried blood spots: application to a pharmacokinetic study in
Trichuris trichiura
-infected adults
. Analytical Methods 10:24, pages 2901-2909.
Crossref
Crossref
Tony K. L. Kiang, Kyle John Wilby & Mary H. H. Ensom. 2018. Drug Interactions in Infectious Diseases: Antimicrobial Drug Interactions. Drug Interactions in Infectious Diseases: Antimicrobial Drug Interactions
515
549
.
Kevin C. Kobylinski, Ratawan Ubalee, Alongkot Ponlawat, Chanyapat Nitatsukprasert, Siriporn Phasomkulsolsil, Thanaporn Wattanakul, Joel Tarning, Kesara Na-Bangchang, Patrick W. McCardle, Silas A. Davidson & Jason H. Richardson. (2017) Ivermectin susceptibility and sporontocidal effect in Greater Mekong Subregion Anopheles. Malaria Journal 16:1.
Crossref
Crossref
Carlos Chaccour, Felix Hammann & N. Regina Rabinovich. (2017) Ivermectin to reduce malaria transmission I. Pharmacokinetic and pharmacodynamic considerations regarding efficacy and safety. Malaria Journal 16:1.
Crossref
Crossref
Carlos J. Chaccour, Felix Hammann, Marta Alustiza, Sandra Castejon, Brian B. Tarimo, Gloria Abizanda, Ángel Irigoyen Barrio, Helena Martí Soler, Rafael Moncada, José Ignacio Bilbao, Azucena Aldaz, Marta Maia & José Luis Del Pozo. (2017) Cytochrome P450/ABC transporter inhibition simultaneously enhances ivermectin pharmacokinetics in the mammal host and pharmacodynamics in Anopheles gambiae. Scientific Reports 7:1.
Crossref
Crossref
S. M. M. Nakayama, Y. Ikenaka, A. Hayami, H. Mizukawa, W. S. Darwish, K. P. Watanabe, Y. K. Kawai & M. Ishizuka. (2016)
Characterization of equine cytochrome P450: role of
CYP
3A in the metabolism of diazepam
. Journal of Veterinary Pharmacology and Therapeutics 39:5, pages 478-487.
Crossref
Crossref
Manuel Wohde, Wolf U. Blanckenhorn, Kevin D. Floate, Joost Lahr, Jean‐Pierre Lumaret, Jörg Römbke, Adam Scheffczyk, Thomas Tixier & Rolf‐Alexander Düring. (2016) Analysis and dissipation of the antiparasitic agent ivermectin in cattle dung under different field conditions. Environmental Toxicology and Chemistry 35:8, pages 1924-1933.
Crossref
Crossref
Li-Ping Chen, Pan Wang, Ying-Jian Sun & Yi-Jun Wu. (2016)
Direct interaction of avermectin with epidermal growth factor receptor mediates the penetration resistance in
Drosophila
larvae
. Open Biology 6:4, pages 150231.
Crossref
Crossref
Carlos J Chaccour, N Regina Rabinovich, Hannah Slater, Sara E Canavati, Teun Bousema, Marcus Lacerda, Feiko ter Kuile, Chris Drakeley, Quique Bassat, Brian D Foy & Kevin Kobylinski. (2015) Establishment of the Ivermectin Research for Malaria Elimination Network: updating the research agenda. Malaria Journal 14:1.
Crossref
Crossref
Elham Badavi, Babak Safavi, Amir Jalali, Ghazaleh Mohammadzadeh Shahriary, Javad Mohammadi-Asl & Javad Babaei. (2015) Association of CYP3A4 and CYP3A5 polymorphisms with Iranian breast cancer patients. Egyptian Journal of Medical Human Genetics 16:3, pages 219-225.
Crossref
Crossref
Roz Laing, David J. Bartley, Alison A. Morrison, Andrew Rezansoff, Axel Martinelli, Steven T. Laing & John S. Gilleard. (2015) The cytochrome P450 family in the parasitic nematode Haemonchus contortus. International Journal for Parasitology 45:4, pages 243-251.
Crossref
Crossref
James S. McCarthy & Thomas A. Moore. 2015. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases
519
527.e3
.
Eva Tydén, Hans Tjälve & Pia Larsson. (2014) Gene and protein expression and cellular localisation of cytochrome P450 enzymes of the 1A, 2A, 2C, 2D and 2E subfamilies in equine intestine and liver. Acta Veterinaria Scandinavica 56:1.
Crossref
Crossref
Mélanie Albérich, Cécile Ménez, Jean-François Sutra & Anne Lespine. (2014) Ivermectin exposure leads to up-regulation of detoxification genes in vitro and in vivo in mice. European Journal of Pharmacology 740, pages 428-435.
Crossref
Crossref
Kazuhisa Fujimoto, Yushi Kawasaki, Kensuke Morimoto, Izumi Kikuchi & Seiji Kawana. (2014) Treatment for Crusted Scabies: Limitations and Side Effects of Treatment with Ivermectin. Journal of Nippon Medical School 81:3, pages 157-163.
Crossref
Crossref
IVAN VOKŘÁL, VERONIKA JEDLIČKOVÁ, ROBERT JIRÁSKO, LUCIE STUCHLÍKOVÁ, HANA BÁRTÍKOVÁ, LENKA SKÁLOVÁ, JIŘÍ LAMKA, MICHAL HOLČAPEK & BARBORA SZOTÁKOVÁ. (2012)
The metabolic fate of ivermectin in host (
Ovis aries
) and parasite (
Haemonchus contortus
)
. Parasitology 140:3, pages 361-367.
Crossref
Crossref
E. TYDÉN, M. LÖFGREN, S. PEGOLO, F. CAPOLONGO, H. TJÄLVE & P. LARSSON. (2012) Differential gene expression of CYP3A isoforms in equine liver and intestines. Journal of Veterinary Pharmacology and Therapeutics 35:6, pages 588-595.
Crossref
Crossref
Marlene Areskog, Georg von Samson-Himmelstjerna, Michel Alvinerie, Jean-François Sutra & Johan Höglund. (2012) Dexamethasone treatment interferes with the pharmacokinetics of ivermectin in young cattle. Veterinary Parasitology 190:3-4, pages 482-488.
Crossref
Crossref
Roger Prichard, Cécile Ménez & Anne Lespine. (2012) Moxidectin and the avermectins: Consanguinity but not identity. International Journal for Parasitology: Drugs and Drug Resistance 2, pages 134-153.
Crossref
Crossref
D.J. Bartley, A.A. Morrison, J. Dupuy, Y. Bartley, J.F. Sutra, C. Menez, M. Alvinerie, F. Jackson, L. Devin & A. Lespine. (2012) Influence of Pluronic 85 and ketoconazole on disposition and efficacy of ivermectin in sheep infected with a multiple resistant Haemonchus contortus isolate. Veterinary Parasitology 187:3-4, pages 464-472.
Crossref
Crossref
Edward Croom. 2012. Toxicology and Human Environments. Toxicology and Human Environments
31
88
.
Juan Guillermo Cárcamo, Marcelo N. Aguilar, Claudia A. Barrientos, Constanza F. Carreño, Claudia A. Quezada, Carlos Bustos, René A. Manríquez, Rubén Avendaño-Herrera & Alejandro J. Yañez. (2011) Effect of emamectin benzoate on transcriptional expression of cytochromes P450 and the multidrug transporters (Pgp and MRP1) in rainbow trout (Oncorhynchus mykiss) and the sea lice Caligus rogercresseyi. Aquaculture 321:3-4, pages 207-215.
Crossref
Crossref
Mikako HIROTA, Tosifusa TODA, Hiraku MORISAWA & Satoru MINESHITA. (2011) A Case Report of Ivermectin-Induced Prolonged Liver Dysfunction in an Elderly Patient with Scabies. Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics 42:5, pages 341-343.
Crossref
Crossref
Geoffrey Edwards. 2011. Drug Interactions in Infectious Diseases. Drug Interactions in Infectious Diseases
581
611
.
Márton Jani, Ildikó Makai, Emese Kis, Pál Szabó, Tünde Nagy, Péter Krajcsi & Anne Lespine. (2011) Ivermectin Interacts With Human ABCG2. Journal of Pharmaceutical Sciences 100:1, pages 94-97.
Crossref
Crossref
William Kudzi, Alexander NO Dodoo & Jeremy J Mills. (2010) Genetic polymorphisms in MDR1, CYP3A4 and CYP3A5 genes in a Ghanaian population: a plausible explanation for altered metabolism of ivermectin in humans?. BMC Medical Genetics 11:1.
Crossref
Crossref
Eugene G. Hrycay & Stelvio M. Bandiera. 2010. Pharmaceutical Sciences Encyclopedia. Pharmaceutical Sciences Encyclopedia
1
70
.
A LifschitzM BallentG VirkelJ Sallovitz & C Lanusse. (2006) Sex-related differences in the gastrointestinal disposition of ivermectin in the rat: P-glycoprotein involvement and itraconazole modulation. Journal of Pharmacy and Pharmacology 58:8, pages 1055-1062.
Crossref
Crossref
THOMAS A. MOORE. 2010. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases
631
668
.
Matthew G. McDonald, Mark J. Rieder, Mariko Nakano, Clara K. Hsia & Allan E. Rettie. (2009)
CYP4F2 Is a Vitamin K
1
Oxidase: An Explanation for Altered Warfarin Dose in Carriers of the V433M Variant
. Molecular Pharmacology 75:6, pages 1337-1346.
Crossref
Crossref
Stefan Balaz. (2009) Modeling Kinetics of Subcellular Disposition of Chemicals. Chemical Reviews 109:5, pages 1793-1899.
Crossref
Crossref
Ursula K. Mayer, Katharina Glos, Matthias Schmid, Helen T. Power, Sonya V. Bettenay & Ralf S. Mueller. (2008) Adverse effects of ketoconazole in dogs – a retrospective study. Veterinary Dermatology 19:4, pages 199-208.
Crossref
Crossref
L. ALVAREZ, A. LIFSCHITZ, C. ENTROCASSO, J. MANAZZA, L. MOTTIER, B. BORDA, G. VIRKEL & C. LANUSSE. (2008) Evaluation of the interaction between ivermectin and albendazole following their combined use in lambs. Journal of Veterinary Pharmacology and Therapeutics 31:3, pages 230-239.
Crossref
Crossref
. (2008) Guideline for the diagnosis and treatment of scabies in Japan (second edition). The Journal of Dermatology 35:6, pages 378-393.
Crossref
Crossref
Ahmed El-Tahtawy, Paul Glue, Emma N. Andrews, Jack Mardekian, Guy W. Amsden & Charles A. Knirsch. (2008) The Effect of Azithromycin on Ivermectin Pharmacokinetics—A Population Pharmacokinetic Model Analysis. PLoS Neglected Tropical Diseases 2:5, pages e236.
Crossref
Crossref
Aránzazu González Canga, Ana M. Sahagún Prieto, M. José Diez Liébana, Nélida Fernández Martínez, Matilde Sierra Vega & Juan J. García Vieitez. (2008) The Pharmacokinetics and Interactions of Ivermectin in Humans—A Mini-review. The AAPS Journal 10:1, pages 42-46.
Crossref
Crossref
J Dupuy, G Larrieu, J.F Sutra, A Lespine & M Alvinerie. (2003) Enhancement of moxidectin bioavailability in lamb by a natural flavonoid: quercetin. Veterinary Parasitology 112:4, pages 337-347.
Crossref
Crossref
Donald J. AbrahamRobert K. Griffith. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery
1090
1096
.
Takanori IKEDA. (2003) Pharmacological effects of ivermectin, an antiparasitic agent for intestinal strongyloidiasis: its mode of action and clinical efficacy.. Folia Pharmacologica Japonica 122:6, pages 527-538.
Crossref
Crossref
Dur-Zong Hsu, Ching-Hung Hsu, Bu-Miin Huang & Ming-Yie Liu. (2001) Abamectin effects on aspartate aminotransferase and nitric oxide in rats. Toxicology 165:2-3, pages 189-193.
Crossref
Crossref
Lenka Skálová, Barbora Szotáková, Miroslav Machala, Jiřı́ Neča, Pavel Souček, Jana Havlasová, Vladimı́r Wsól, Lenka Křı́dová, Eva Kvasničková & Jiřı́ Lamka. (2001) Effect of ivermectin on activities of cytochrome P450 isoenzymes in mouflon (Ovis musimon) and fallow deer (Dama dama). Chemico-Biological Interactions 137:2, pages 155-167.
Crossref
Crossref
J. Dupuy, G. Larrieu, J. F. Sutra, C. Eeckhoutte & M. Alvinerie. (2001)
Influence of verapamil on the efflux and metabolism of
14
C moxidectin in cultured rat hepatocytes
. Journal of Veterinary Pharmacology and Therapeutics 24:3, pages 171-177.
Crossref
Crossref
I M Davies & G K Rodger. (2000)
A review of the use of ivermectin as a treatment for sea lice [
Lepeophtheirus salmonis
(Krøyer) and
Caligus elongatus
Nordmann] infestation in farmed Atlantic salmon (
Salmo salar
L.)
. Aquaculture Research 31:11, pages 869-883.
Crossref
Crossref
Vanessa Baier, Alicia Paini, Stephan Schaller, Colin G. Scanes, Audrey Bone, Markus Ebeling, Thomas G. Preuss, Johannes Witt & David Heckmann. (2022) A Generic Avian Physiologically-Based Kinetic (Pbk) Model and its Application in Three Bird Species. SSRN Electronic Journal.
Crossref
Crossref